EUVIMEDEUVIMED entdecken
EditorialKommentar

Improved outcome with individualised antifibrinolytic therapy: what is the evidence?

Daniel Bolliger, Marco Ranucci

British Journal of Anaesthesia · 2024

DOI: 10.1016/j.bja.2024.03.020 ↗

Kurz gefasst

Editorial in der Zeitschrift British Journal of Anaesthesia, 2024. Verfasst von Daniel Bolliger und 1 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Anaesthesia, Intermediate Care, Prehospital Emergency Medicine and Pain Therapy, University Hospital Basel, University of Basel, Basel, Sw…. Hauptthemen laut MEDLINE: Antifibrinolytic Agents. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viscoelastic haemostatic testing (VHT) has been used to determine hyperfibrinolysis and hypofibrinolysis. When modified by addition of tissue plasminogen activator (tPA), VHT has been suggested to assess responses to antifibrinolytic therapy and to estimate the concentration of tranexamic acid in patients undergoing cardiac surgery. Despite some evidence that tPA-modified VHT might allow individualisation of antifibrinolytic therapy, further studies are warranted to prove its clinical benefit for postsurgical bleeding, transfusion of blood products, and thromboembolic events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifibrinolytic AgentsHumansPostoperative HemorrhagePrecision MedicineThrombelastographyTissue Plasminogen ActivatorTranexamic AcidTreatment Outcome

Stichwörter der Autor:innen

cardiac surgerycoagulationfibrinolysistranexamic acidviscoelastic testing

Substanzen

Antifibrinolytic AgentsTissue Plasminogen ActivatorTranexamic Acid

Autor:innen und Institutionen

  • Clinic for Anaesthesia, Intermediate Care, Prehospital Emergency Medicine and Pain Therapy, University Hospital Basel, University of Basel, Basel, Switzerland. Electronic address: daniel.bolliger@usb.ch.
  • Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Zitieren

APA

Bolliger, D., & Ranucci, M. (2024). Improved outcome with individualised antifibrinolytic therapy: what is the evidence?. British Journal of Anaesthesia. https://doi.org/10.1016/j.bja.2024.03.020

Vancouver

Bolliger D, Ranucci M. Improved outcome with individualised antifibrinolytic therapy: what is the evidence?. British Journal of Anaesthesia. 2024. doi:10.1016/j.bja.2024.03.020

BibTeX
@article{Bolliger2024,
  author = {Bolliger, Daniel and Ranucci, Marco},
  title = {Improved outcome with individualised antifibrinolytic therapy: what is the evidence?},
  journal = {British Journal of Anaesthesia},
  year = {2024},
  doi = {10.1016/j.bja.2024.03.020}
}
Kostenlos starten →